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Pulse oximetry screening (POS) is an accepted test that improves detection of critical 
congenital heart defects (CCHD).
1
 Although outcome data are lacking, there is 
agreement among clinicians that POS identifies babies with CCHD before discharge.  
Following consideration by an expert workgroup, POS was adopted onto the US 
Recommended Uniform Screening Panel 
2
 and other countries have either introduced, 
or are considering introducing, POS.
1
  Despite this, there is considerable variation in 
screening, particularly the algorithm used.
3
  
Differences include: i) pre- and post-ductal saturations (right hand and either foot) 
versus single post-ductal measurement (foot only) and ii) timing of screening (i.e. 
before or after 24 hours). In algorithms using two limb measurements there are also 
differences - inclusion of saturations <95% in one or both limbs and the absolute 
value of the differential between the two in determining positive results.
1
 So, which 
algorithm is best? 
 
When evaluating algorithms, it is important to consider sensitivity, specificity, false 
positive (FP) and false negative rate. It is also vital that screening leads to timely 
diagnosis - before presentation with acute collapse. Meta-analysis of POS studies 
shows that overall, the test has modest sensitivity (~ 75%) and high specificity 
(99.8%), with no significant difference in sensitivity between pre/post vs. post-ductal 
testing or timing.
3
   However, analysis of raw saturation data from babies who had 
both limb measurements, shows that some babies with CCHD would be missed by 
post-ductal testing alone.
1
 In addition, the FP rate is significantly higher with earlier 
testing (<24 hrs).
3
 These factors were deemed important by the USA workgroup 
considering the POS evidence and their recommendation was that screening should 
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include both pre/post measurements and be performed after 24 hours.
2
 This resulted in 
the algorithm introduced in the USA (figure 1).
2
  
A low FP rate is clearly important; but the strict definition of a FP is any test positive 
baby who does not have CCHD. Interestingly, analysis of recent POS studies shows 
that many FPs (30-80%) have alternative non-cardiac conditions (e.g. congenital 
pneumonia, early-onset sepsis or pulmonary hypertension), which may be as equally 
life-threatening as CCHD if diagnosed late.
1,4-6
  These conditions may benefit from 
earlier diagnosis and represent an important additional advantage.  Also, important 
non-critical cardiac defects (e.g. AVSD, VSD) are identified as FPs.
1,4-6
 .  
 
Timing of the test 
In published studies that adopted earlier screening,
3,6
 the FP rate was higher, but more 
non-cardiac disease was identified; this is because such babies are more likely to 
develop hypoxemia within 24 hours and therefore be picked up by earlier screening.  
Careful analysis of later screening studies
4,5
 reveals important additional findings. In 
Granelli’s
4
 and Riede’s
5
 studies, half of eligible babies with CCHD, presented with 
symptoms before screening could take place; 28/57 babies with CCHD in Granelli’s 
and 18/36 in Riede’s. In Granelli’s,
4
 Over 10% of babies with CCHD (6/57) presented 
with acute collapse in hospital - the very situation that screening aims to prevent. It is 
well documented that babies with CCHD who collapse prior to surgery have worse 
outcomes and greater risk of neuro-developmental complications,
1
 so these potentially 
avoidable collapses (i.e. if screening was earlier) may have significant consequences. 
Although earlier screening results in more test positive babies, it is important to 
balance a low FP rate with timely diagnosis. Some FP babies will be healthy- having 
transitional circulation - but others have life-threatening non-cardiac conditions and 
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the earlier these are identified, the better. In some countries, mothers and babies are 
discharged from hospital within 24 hours following birth and an increasing proportion 
is born at home. In these circumstances, later screening in hospital is not practical. 
UK evidence  - screening at a mean age of seven hours - reported a test positive 
rate of 0.8%7 (similar to PulseOx study6) With around 26 000 babies screened, 
nine CCHDs were identified and, within the FPs, 79% had a significant medical 
condition. One of the major concerns regarding a high FP rate is the increased 
need for specialist assessment - particularly echocardiography - which can be 
challenging in some areas. Only 29% of test-positive babies in the UK study 
underwent echocardiography (mainly because an alternative non-cardiac 
diagnosis was established) and the echo was positive in 48%.7 This compared 
favorably with babies in the same unit undergoing echocardiography for 
asymptomatic murmur7 
The experience following the introduction of POS in New Jersey was recently 
reported.8 Almost 73 000 babies were screened (after 24 hours) and the FP rate 
was 0.04%. However only three babies with CCHD and only 12 babies with non-
cardiac conditions were detected. Although the FP rate is admirably low, the 
number of babies with CCHD is also very low. In the UK it took 2873 screens to 
detect one CCHD vs. 24 231 screens in the US.7 The likelihood is, that in the US 
cohort, many babies with CCHD presented before screening took place. These 
important considerations led to the Nordic countries recommending screening at 
<24 hours9 
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Differences in definition of a test positive result 
The UK study used the PulseOx6 algorithm, which in addition to a difference in 
timing, has subtle differences in the definition of test positivity (figure 2). In the 
US algorithm, test positivity is defined as saturation <90% in either limb or 
saturations between 90-94% in both limbs, or a difference of >3% between the 
two, on 3 separate occasions (i.e. two retests each after 1 hour, before clinical 
assessment).  In the UK, a test positive saturation must be 90-94% in either limb 
or a difference of >2% on two occasions (i.e. one retest after 2 hours which is 
preceded by clinical assessment).  
Do these minor differences matter? Examining the raw pre/post saturation data 
from both studies and applying the US protocol to the PulseOx patients would 
have missed one CCHD (detected prenatally) and 2 serious CHDs. These numbers 
are small but may be important when scaled up nationally; further evidence is 
required before a precise estimate of the difference can be stated with 
conviction. The application of a second retest almost certainly reduces the FP 
rate (babies with transitional circulation improve between screens) but as the 
majority (up to 80%) of babies who test positive after one retest have a 
significant condition,7 the second retest before clinical assessment potentially 
introduces a delay in diagnosis and treatment, which may result in a worse 
outcome. 
So, should the US screening algorithm remain as it is, or should a change be 
considered? Countries wishing to introduce screening may, quite rightly, wish to 
follow tried and tested practice but unfortunately there are limited data 
reporting outcomes of US screening. Further research is probably unnecessary, 
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however collection and analysis of saturation data from populations already 
being screened is required to refine the minor differences in the algorithm.  
The evidence to support a change in timing is perhaps more convincing, but is 
important to accept that test positives will increase (to around 0.8%) with 
earlier screening and many non-cardiac conditions are identified in addition. 
POS uses hypoxemia as a proxy for CCHD and does not detect CCHD directly. 
Given this, should we screen for all hypoxemic conditions rather than just CCHD? 
The concern is that hypoxemia is not a condition as such and newborns may 
have ‘physiological’ hypoxemia as the cardio-respiratory systems adapt to extra-
uterine life. Once again the earlier screening takes place the more likely this 
‘transitional circulation’ is identified in test positive babies. The other major 
concern is although we have good data for CCHD, there are no robust data on the 
accuracy of POS for non-cardiac conditions. This presents difficulties for Public 
Health decision-makers sanctioning POS as a valid test for these conditions. 
Perhaps the best compromise is to continue POS for CCHD and accept that babies 
detected with non-cardiac conditions (technically FPs, but could be considered 
secondary targets) are an important additional benefit. Clinical staff and parents 
should be made aware of this. 
 
Until these issues are resolved and more data forthcoming, is it worth 
considering an algorithm which has a consistent slightly higher FP rate but will 
potentially identify more babies with life-threatening disease? 
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Figure 1. USA algorithm 
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Figure 2 UK algorithm  
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